Cleared Traditional

MyHomeDoc (K202483) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202483 · Myhomedoc , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2021
Decision
207d
Days
Class 2
Risk

K202483 is an FDA 510(k) clearance for the MyHomeDoc. Classified as Stethoscope, Electronic (product code DQD), Class II - Special Controls.

Submitted by Myhomedoc , Ltd. (Ra'Anana, IL). The FDA issued a Cleared decision on March 23, 2021 after a review of 207 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Myhomedoc , Ltd. devices

Submission Details

510(k) Number K202483 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 2020
Decision Date March 23, 2021
Days to Decision 207 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d slower than avg
Panel avg: 125d · This submission: 207d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQD Stethoscope, Electronic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1875
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Hogan Lovells US LLP
Jonathan Kahan

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQD Stethoscope, Electronic

All 53
Devices cleared under the same product code (DQD) and FDA review panel - the closest regulatory comparables to K202483.
eKuore Pro 4T - REF EP0098
K212013 · Chip Ideas Electronics S.L. · Nov 2021
PrevisEA Device
K211068 · Entac Medical, Inc. · Aug 2021
doctorgram Stethoscope DES-I
K210736 · Gv Concepts · Jul 2021
eKuore One Wireless Electronic Interface for stethoscope
K201742 · Chip Ideas Electronics S.L. · Nov 2020
eKuore Pro Series
K203007 · Chip Ideas Electronics S.L. · Oct 2020
Stethee Pro 1, Stethee Pro Software System
K193631 · M3Dicine Pty , Ltd. · Oct 2020